Clinuvel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 40.31% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.6%	BNY Asset Management	4,296,471	€35.0m	11.5%	0.01%
6.86%	Philippe Wolgen	3,425,222	€27.9m	0%	no data
5.19%	Ender I , LLC	2,590,824	€21.1m	0%	no data
4.74%	The Vanguard Group, Inc.	2,368,376	€19.3m	18.8%	no data
2.77%	JPMorgan Chase & Co, Brokerage and Securities Investments	1,383,750	€11.3m	6.91%	0.01%
1.85%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	923,510	€7.5m	10.9%	no data
1.5%	Dimensional Fund Advisors LP	747,709	€6.1m	0.3%	no data
1.2%	Emilino Group Pty Ltd	601,447	€4.9m	-0.33%	no data
1.07%	BlackRock, Inc.	533,946	€4.3m	1.25%	no data
0.87%	Norges Bank Investment Management	437,018	€3.6m	0%	no data
0.73%	Darren Keamy	362,890	€3.0m	0%	no data
0.69%	Mark Badcock	346,772	€2.8m	-21.2%	no data
0.46%	David Trevorrow	229,600	€1.9m	0%	no data
0.46%	BNP Paribas Arbitrage Sa, Asset Management Arm	229,044	€1.9m	0%	no data
0.45%	AllianceBernstein L.P.	222,988	€1.8m	1.2%	no data
0.38%	Dennis Wright	188,812	€1.5m	0%	no data
0.37%	David Lewis	185,000	€1.5m	-1.07%	no data
0.36%	Trent Redding	177,370	€1.4m	-1.18%	no data
0.3%	Spheria Asset Management Pty Ltd	152,159	€1.2m	0%	0.24%
0.3%	Spheria Emerging Companies Limited	152,159	€1.2m	0%	no data
0.3%	Rusty Hammer Pty Ltd	150,722	€1.2m	-3.93%	no data
0.29%	Simon Bown	146,000	€1.2m	0%	no data
0.23%	Brenda Shanahan	116,577	€948.7k	0%	no data
0.17%	Charles Schwab Investment Management, Inc.	82,777	€673.6k	0%	no data
0.16%	Brenda Shanahan Charitable Foundation., Endowment Arm	80,000	€651.0k	0%	no data